Global /United States /Healthcare /Diagnostics & Research /RNVA
chevron_leftBack

Rennova Health, Inc.

RNVA
OTCMKTS: RNVA Delayed
0.0001USD 0%
As of 24 April 2025, Rennova Health, Inc. has a market cap of $43.05K USD, ranking #39090 globally and #5636 in the United States. It ranks #3979 in the Healthcare sector, and #214 in the Diagnostics & Research industry.
Global Rank
39090
Country Rank
5636
Sector Rank
3979
Industry Rank
214
Key Stats
Market Cap
$43.05KUSD
Revenue (TTM)
$18.69MUSD
EBITDA (TTM)
$1.68MUSD
Net Income (TTM)
-$7.73MUSD
EBITDA Margin
9%
Profit Margin
-41%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Seamus Lagan open_in_new
Employees
149
Website
rennovahealth.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% -99% -99% -99% 0% -99%

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
RNVA
Rennova Health Inc
ISIN: US7597578670
Shares Out.:
43.051B1 Shares Float: 43.051B2
TV:
SA:
YF:
GF:
BA:
MS:
0.0001 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Rennova Health, Inc.

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a hospital located in Jamestown, Tennessee. The company is based in West Palm Beach, Florida.

Similar Companies

Industry: Diagnostics & Research (United States)
Name
Market Cap diff.
Thermo Fisher Scientific Inc.
TMO
$162.94B
378M%
Danaher Corp.
DHR
$140.49B
326M%
IDEXX Laboratories, Inc.
IDXX
$34.57B
80M%
Agilent Technologies, Inc.
A
$29.94B
70M%
IQVIA Holdings Inc.
IQV
$25.93B
60M%
Industry: Diagnostics & Research (Global)
Name
Market Cap diff.
Lonza Group AG
LONN
$46.75B
38.79B CHF
109M%
WuXi AppTec Co., Ltd.
603259
$22.16B
161.5B CNY
51M%
bioMérieux S.A.
BIM
$15.23B
13.39B EUR
35M%
ICON Public Limited Co.
ICLR
$11.56B
27M%
Eurofins Scientific SE
ERF
$11.46B
10.07B EUR
27M%